Nursing and Health Professions
Patient
100%
Carboplatin
41%
Dose
33%
Child
33%
Toxicity
16%
Continuous Infusion
16%
Intravenous Drug Administration
16%
Remission
16%
Acute Leukemia
16%
Etoposide
16%
Infection
8%
Bleeding
8%
Diarrhea
8%
Childhood Cancer
8%
Procedures
8%
Aplasia
8%
Antileukemic Agent
8%
Medicine and Dentistry
Carboplatin
41%
Spontaneous Remission
16%
Continuous Infusion
16%
Toxicity
16%
Intravenous Drug Administration
16%
Acute Leukemia
16%
Phase I Trials
16%
Etoposide
16%
Therapeutic Procedure
16%
Bleeding
8%
Childhood Cancer
8%
Infection
8%
Diarrhea
8%
Life
8%
Aplasia
8%
Antileukemic Agent
8%
Pharmacology, Toxicology and Pharmaceutical Science
Carboplatin
41%
Phase II Trials
16%
Toxicity
16%
Acute Leukemia
16%
Remission
16%
Etoposide
16%
Diarrhea
8%
Infection
8%
Bleeding
8%
Childhood Cancer
8%
Aplasia
8%
Neuroscience
Carboplatin
41%
Etoposide
16%
Suppression
8%
Pediatrics
8%
Immunology and Microbiology